Ocular myopathy myasthenia gravis which had a higher success rate, few complications, lower re1apse rate and may be the first method.
揭示联合用药治疗眼肌型重症肌无力治愈率高，减少了用药量和药物并发症，复发率低，应作为本病的首选治疗方法。
Ocular myopathy myasthenia gravis which had a higher success rate, few complications, lower re1apse rate and may be the first method.
揭示联合用药治疗眼肌型重症肌无力治愈率高，减少了用药量和药物并发症，复发率低，应作为本病的首选治疗方法。
应用推荐